Brenus Pharma Email Format
Biotechnology ResearchAuvergne-rhône-alpes, France11-50 Employees
Brenus Pharma is a clinical-stage biotechnology company based in Lyon, Auvergne-Rhône-Alpes, France, focused on preventing cancer recurrence in solid tumors. The company is developing a next-generation cancer treatment using an allogeneic platform that educates the immune system and aims to broaden the range of therapeutic targets. Its lead candidate targets colorectal cancer, the second leading cause of cancer deaths worldwide. Its approach seeks to combine enhanced immunogenicity with standardized GMP manufacturing to support reliable production and supply. Brenus Pharma is pursuing clinical collaborations and recently publicized presenting preclinical and early clinical data on colorectal cancer at the AACR immuno-oncology conference in 2026.